Issue |
BIO Web Conf.
Volume 86, 2024
International Conference on Recent Trends in Biomedical Sciences (RTBS-2023)
|
|
---|---|---|
Article Number | 01036 | |
Number of page(s) | 5 | |
DOI | https://doi.org/10.1051/bioconf/20248601036 | |
Published online | 12 January 2024 |
Exploration of Baicalin analogues against main Protease involved in Covid-19 as potential inhibitors involving in silico approaches
1 Chitkara College of Pharmacy, Chitkara University, Punjab, India
2 School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab - 144411
* Corresponding author: manjinder.singh@chitkara.edu.in
The proteolytic enzymesinvolved in the processing and replication of coronavirus serve a promising drug targetsfor coronavirus. Although a few numbers of vaccines have been made available, there is a great need for effective treatment to manageit. The current study involved the exploration of baicalin analogues as potential inhibitor of viral proteolytic enzyme. Utilizing various computational tools (scaffold morphing, molecular docking and pharmacokinetic studies), the B74 and B86 analogueswere screened as potential inhibitors of main protease. Accordingly, these analogues can be explored further in the search of promising therapy against the coronavirus infection.
© The Authors, published by EDP Sciences, 2024
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.